Regen BioPharma Inc (RGBP)

[My2b]

The 12 Abandoned Patents list to be revived.

REGEN BIOPHARMA INC : Other Events (form 8-K)
05/07/2021 | 02:44pm EDT

Regen Biopharma, Inc. (the "Company") has begun the process of reviving patent applications of the Company filed with the United States Patent and Trademark Office ("USPTO") which have been classified as abandoned by the USPTO.

Legal services in connection with the abovementioned revival activities are being provided by Marc Baumgartner of Baumgartner Patent Law. Mr. Baumgartner has over 20 years of experience in the field of intellectual property law.

Application/PCT #Title of InventionStatus that may be revived...

13897735
ACCELERATION OF HEMATOPOIETIC RECONSTITUTION BY PLACENTAL ENDOTHELIAL AND ENDOTHELIAL PROGENITOR CELLS
Abandoned -- Failure To Respond To An Office Action

13957427
CELLS, COMPOSITIONS, AND TREATMENT METHODS FOR STIMULATION OF HEMATOPOIESIS
Abandoned -- Failure To Respond To An Office Action

13957431
CANCER THERAPY BY EX VIVO ACTIVATED AUTOLOGOUS IMMUNE CELLS
Abandoned -- Failure To Respond To An Office Action

14854136
STIMULATION OF IMMUNITY TO TUMOR SPECIFIC AND ENDOTHELIAL SPECIFIC PROTEINS BY IN VIVO DC ATTRACTION AND MATURATION
Abandoned -- Failure To Respond To An Office Action

14954902
IMMUNE MODULATION BY TLR ACTIVATION FOR TREATMENT OF FILOVIRUS INFECTIONS INCLUDING EBOLA
Abandoned -- Failure To Respond To An Office Action

15162370
ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES
Response To Non-Final Office Action Entered And Forwarded To Examiner

15250877
TREATMENT OF LIVER CANCER THROUGH EMBOLIZATION DEPOT DELIVERY OF BORIS GENE SILENCING AGENTS
Abandoned -- Failure To Respond To An Office Action

15364111
SMALL MOLECULE MODULATORS OF NR2F6 ACTIVITY
Response To Non-Final Office Action Entered And Forwarded To Examiner

15431681
METHODS AND MEANS OF GENERATING IL-17 ASSOCIATED ANTITUMOR EFFECTOR CELLS BY INHIBITION OF NR2F6 INHIBITION
Abandonment For Failure To Correct Drawings/Oath/NonPub Request

15494358
UNIVERSAL DONOR CHECKPOINT INHIBITOR SILENCED/GENE EDITED CORD BLOOD KILLER CELLS
Abandoned -- Failure To Pay Issue Fee

17010720
STIMULATION OF T REGULATORY CELLS BY CANNABIDIOL AS A MEANS OF TREATING ARTHRITIS AND AUTOIMMUNITY
Application Dispatched From Preexam, Not Yet Docketed

62363588
SMALL MOLECULE MODULATORS OF NR2F6 ACTIVITY
Provisional Application Expired